Academic Journal

A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice
Συγγραφείς: Errico F., D'Argenio V., Sforazzini F., Iasevoli F., Squillace M., Guerri G., Napolitano F., Angrisano T., Di Maio A., Keller S., Vitucci D., Galbusera A., Chiariotti L., Bertolino A., De Bartolomeis A., Salvatore F., Gozzi A., Usiello A.
Συνεισφορές: Errico, F., D'Argenio, V., Sforazzini, F., Iasevoli, F., Squillace, M., Guerri, G., Napolitano, F., Angrisano, T., Di Maio, A., Keller, S., Vitucci, D., Galbusera, A., Chiariotti, L., Bertolino, A., De Bartolomeis, A., Salvatore, F., Gozzi, A., Usiello, A.
Έτος έκδοσης: 2015
Συλλογή: Università degli Studi di Bari Aldo Moro: CINECA IRIS
Θεματικοί όροι: Adult, Animal, Behavior, Brain, Case-Control Studie, D-Aspartate Oxidase, DNA Methylation, Disease Models, Excitatory Amino Acid Antagonist, Female, Functional Neuroimaging, Human, Magnetic Resonance Imaging, Male, Mice, Knockout, Middle Aged, Motor Activity, Phencyclidine, Prefrontal Cortex, Prepulse Inhibition, Schizophrenia
Περιγραφή: Pharmacogenetics may allow for a personalized treatment, but a combination with clinical variables may further enhance prediction. In particular, in the present paper, we investigated early partial improvement (EPI) defined as 20% or more improvement by rating scales 2weeks after treatment, in combination with selected gene variants as a predictor of treatment outcome in patients with major depressive disorder. Two randomized controlled trials with 168 Japanese depressed patients were used. A stepwise multiple linear regression model with HAM-D score change at week 6 as the dependent variable and genotypes, EPI, baseline HAM-D score, age and sex as independent variables was performed in paroxetine, fluvoxamine and milnacipran, respectively, to estimate the prediction of HAM-D change at week 6. In the paroxetine sample, only EPI (P<0.001) was significantly associated with HAM-D change (n=81, R 2 =0.25, P<0.001). In the fluvoxamine sample, 5-HTTLPR La/Lg, S (P=0.029), FGF2 rs1449683C/T (P=0.013) and EPI (P=0.003) were associated with HAM-D change (n=42, R 2 =0.43, P<0.001). In the milnacipran sample, HTR-1A-1019C/G (P=0.001), ADRA2A-1297C/G (P=0.028) and EPI (P<0.001) were associated with outcome (n=45, R 2 =0.71, P<0.001). EPI in combination with genetic variants could be a useful predictor of treatment outcome and could strengthen the practical use of pharmacogenetic data in clinical practice.
Τύπος εγγράφου: article in journal/newspaper
Γλώσσα: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/25689573; info:eu-repo/semantics/altIdentifier/wos/WOS:000367652000005; volume:5; issue:2; firstpage:e512; numberofpages:9; journal:TRANSLATIONAL PSYCHIATRY; https://hdl.handle.net/11586/257047; http://www.nature.com/tp/index.html
DOI: 10.1038/tp.2015.2
Διαθεσιμότητα: https://hdl.handle.net/11586/257047
https://doi.org/10.1038/tp.2015.2
http://www.nature.com/tp/index.html
Rights: info:eu-repo/semantics/openAccess ; license:NON PUBBLICO - Accesso privato/ristretto
Αριθμός Καταχώρησης: edsbas.6CD5D327
Βάση Δεδομένων: BASE
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://hdl.handle.net/11586/257047#
    Name: EDS - BASE (ns324271)
    Category: fullText
    Text: View record from BASE
Header DbId: edsbas
DbLabel: BASE
An: edsbas.6CD5D327
RelevancyScore: 850
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 849.549011230469
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Errico+F%2E%22&quot;&gt;Errico F.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22D&#39;Argenio+V%2E%22&quot;&gt;D&#39;Argenio V.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sforazzini+F%2E%22&quot;&gt;Sforazzini F.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Iasevoli+F%2E%22&quot;&gt;Iasevoli F.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Squillace+M%2E%22&quot;&gt;Squillace M.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Guerri+G%2E%22&quot;&gt;Guerri G.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Napolitano+F%2E%22&quot;&gt;Napolitano F.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Angrisano+T%2E%22&quot;&gt;Angrisano T.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Di+Maio+A%2E%22&quot;&gt;Di Maio A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Keller+S%2E%22&quot;&gt;Keller S.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Vitucci+D%2E%22&quot;&gt;Vitucci D.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Galbusera+A%2E%22&quot;&gt;Galbusera A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Chiariotti+L%2E%22&quot;&gt;Chiariotti L.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bertolino+A%2E%22&quot;&gt;Bertolino A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22De+Bartolomeis+A%2E%22&quot;&gt;De Bartolomeis A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Salvatore+F%2E%22&quot;&gt;Salvatore F.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gozzi+A%2E%22&quot;&gt;Gozzi A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Usiello+A%2E%22&quot;&gt;Usiello A.&lt;/searchLink&gt;
– Name: Author
  Label: Contributors
  Group: Au
  Data: Errico, F.&lt;br /&gt;D&#39;Argenio, V.&lt;br /&gt;Sforazzini, F.&lt;br /&gt;Iasevoli, F.&lt;br /&gt;Squillace, M.&lt;br /&gt;Guerri, G.&lt;br /&gt;Napolitano, F.&lt;br /&gt;Angrisano, T.&lt;br /&gt;Di Maio, A.&lt;br /&gt;Keller, S.&lt;br /&gt;Vitucci, D.&lt;br /&gt;Galbusera, A.&lt;br /&gt;Chiariotti, L.&lt;br /&gt;Bertolino, A.&lt;br /&gt;De Bartolomeis, A.&lt;br /&gt;Salvatore, F.&lt;br /&gt;Gozzi, A.&lt;br /&gt;Usiello, A.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2015
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: Universit&#224; degli Studi di Bari Aldo Moro: CINECA IRIS
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Adult%22&quot;&gt;Adult&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Animal%22&quot;&gt;Animal&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Behavior%22&quot;&gt;Behavior&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Brain%22&quot;&gt;Brain&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Case-Control+Studie%22&quot;&gt;Case-Control Studie&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22D-Aspartate+Oxidase%22&quot;&gt;D-Aspartate Oxidase&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22DNA+Methylation%22&quot;&gt;DNA Methylation&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Disease+Models%22&quot;&gt;Disease Models&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Excitatory+Amino+Acid+Antagonist%22&quot;&gt;Excitatory Amino Acid Antagonist&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Female%22&quot;&gt;Female&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Functional+Neuroimaging%22&quot;&gt;Functional Neuroimaging&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Human%22&quot;&gt;Human&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Magnetic+Resonance+Imaging%22&quot;&gt;Magnetic Resonance Imaging&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Male%22&quot;&gt;Male&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Mice%22&quot;&gt;Mice&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Knockout%22&quot;&gt;Knockout&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Middle+Aged%22&quot;&gt;Middle Aged&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Motor+Activity%22&quot;&gt;Motor Activity&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Phencyclidine%22&quot;&gt;Phencyclidine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prefrontal+Cortex%22&quot;&gt;Prefrontal Cortex&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prepulse+Inhibition%22&quot;&gt;Prepulse Inhibition&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Schizophrenia%22&quot;&gt;Schizophrenia&lt;/searchLink&gt;
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Pharmacogenetics may allow for a personalized treatment, but a combination with clinical variables may further enhance prediction. In particular, in the present paper, we investigated early partial improvement (EPI) defined as 20% or more improvement by rating scales 2weeks after treatment, in combination with selected gene variants as a predictor of treatment outcome in patients with major depressive disorder. Two randomized controlled trials with 168 Japanese depressed patients were used. A stepwise multiple linear regression model with HAM-D score change at week 6 as the dependent variable and genotypes, EPI, baseline HAM-D score, age and sex as independent variables was performed in paroxetine, fluvoxamine and milnacipran, respectively, to estimate the prediction of HAM-D change at week 6. In the paroxetine sample, only EPI (P&lt;0.001) was significantly associated with HAM-D change (n=81, R 2 =0.25, P&lt;0.001). In the fluvoxamine sample, 5-HTTLPR La/Lg, S (P=0.029), FGF2 rs1449683C/T (P=0.013) and EPI (P=0.003) were associated with HAM-D change (n=42, R 2 =0.43, P&lt;0.001). In the milnacipran sample, HTR-1A-1019C/G (P=0.001), ADRA2A-1297C/G (P=0.028) and EPI (P&lt;0.001) were associated with outcome (n=45, R 2 =0.71, P&lt;0.001). EPI in combination with genetic variants could be a useful predictor of treatment outcome and could strengthen the practical use of pharmacogenetic data in clinical practice.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article in journal/newspaper
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: info:eu-repo/semantics/altIdentifier/pmid/25689573; info:eu-repo/semantics/altIdentifier/wos/WOS:000367652000005; volume:5; issue:2; firstpage:e512; numberofpages:9; journal:TRANSLATIONAL PSYCHIATRY; https://hdl.handle.net/11586/257047; http://www.nature.com/tp/index.html
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1038/tp.2015.2
– Name: URL
  Label: Availability
  Group: URL
  Data: https://hdl.handle.net/11586/257047&lt;br /&gt;https://doi.org/10.1038/tp.2015.2&lt;br /&gt;http://www.nature.com/tp/index.html
– Name: Copyright
  Label: Rights
  Group: Cpyrght
  Data: info:eu-repo/semantics/openAccess ; license:NON PUBBLICO - Accesso privato/ristretto
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsbas.6CD5D327
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.6CD5D327
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/tp.2015.2
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Adult
        Type: general
      – SubjectFull: Animal
        Type: general
      – SubjectFull: Behavior
        Type: general
      – SubjectFull: Brain
        Type: general
      – SubjectFull: Case-Control Studie
        Type: general
      – SubjectFull: D-Aspartate Oxidase
        Type: general
      – SubjectFull: DNA Methylation
        Type: general
      – SubjectFull: Disease Models
        Type: general
      – SubjectFull: Excitatory Amino Acid Antagonist
        Type: general
      – SubjectFull: Female
        Type: general
      – SubjectFull: Functional Neuroimaging
        Type: general
      – SubjectFull: Human
        Type: general
      – SubjectFull: Magnetic Resonance Imaging
        Type: general
      – SubjectFull: Male
        Type: general
      – SubjectFull: Mice
        Type: general
      – SubjectFull: Knockout
        Type: general
      – SubjectFull: Middle Aged
        Type: general
      – SubjectFull: Motor Activity
        Type: general
      – SubjectFull: Phencyclidine
        Type: general
      – SubjectFull: Prefrontal Cortex
        Type: general
      – SubjectFull: Prepulse Inhibition
        Type: general
      – SubjectFull: Schizophrenia
        Type: general
    Titles:
      – TitleFull: A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Errico F.
      – PersonEntity:
          Name:
            NameFull: D'Argenio V.
      – PersonEntity:
          Name:
            NameFull: Sforazzini F.
      – PersonEntity:
          Name:
            NameFull: Iasevoli F.
      – PersonEntity:
          Name:
            NameFull: Squillace M.
      – PersonEntity:
          Name:
            NameFull: Guerri G.
      – PersonEntity:
          Name:
            NameFull: Napolitano F.
      – PersonEntity:
          Name:
            NameFull: Angrisano T.
      – PersonEntity:
          Name:
            NameFull: Di Maio A.
      – PersonEntity:
          Name:
            NameFull: Keller S.
      – PersonEntity:
          Name:
            NameFull: Vitucci D.
      – PersonEntity:
          Name:
            NameFull: Galbusera A.
      – PersonEntity:
          Name:
            NameFull: Chiariotti L.
      – PersonEntity:
          Name:
            NameFull: Bertolino A.
      – PersonEntity:
          Name:
            NameFull: De Bartolomeis A.
      – PersonEntity:
          Name:
            NameFull: Salvatore F.
      – PersonEntity:
          Name:
            NameFull: Gozzi A.
      – PersonEntity:
          Name:
            NameFull: Usiello A.
      – PersonEntity:
          Name:
            NameFull: Errico, F.
      – PersonEntity:
          Name:
            NameFull: D'Argenio, V.
      – PersonEntity:
          Name:
            NameFull: Sforazzini, F.
      – PersonEntity:
          Name:
            NameFull: Iasevoli, F.
      – PersonEntity:
          Name:
            NameFull: Squillace, M.
      – PersonEntity:
          Name:
            NameFull: Guerri, G.
      – PersonEntity:
          Name:
            NameFull: Napolitano, F.
      – PersonEntity:
          Name:
            NameFull: Angrisano, T.
      – PersonEntity:
          Name:
            NameFull: Di Maio, A.
      – PersonEntity:
          Name:
            NameFull: Keller, S.
      – PersonEntity:
          Name:
            NameFull: Vitucci, D.
      – PersonEntity:
          Name:
            NameFull: Galbusera, A.
      – PersonEntity:
          Name:
            NameFull: Chiariotti, L.
      – PersonEntity:
          Name:
            NameFull: Bertolino, A.
      – PersonEntity:
          Name:
            NameFull: De Bartolomeis, A.
      – PersonEntity:
          Name:
            NameFull: Salvatore, F.
      – PersonEntity:
          Name:
            NameFull: Gozzi, A.
      – PersonEntity:
          Name:
            NameFull: Usiello, A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-locals
              Value: edsbas
            – Type: issn-locals
              Value: edsbas.oa
ResultId 1